Atopic dermatitis: Impact on quality of life and patients' attitudes toward its management

European Journal of Dermatology

Volumn 22, Issue 1, 2012, Pages 97-105

  Torrelo, Antonio ^a   Ortiz, Javier ^b   Alomar, Agustín ^c   Ros, Sandra ^c   Prieto, Marta ^d   Cuervo, Jesús ^e  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d Parque Empresarial La Finca   (Spain)

^e BAP Health Outcomes   (Spain)

Author keywords

Atopic dermatitis; Attitudes; Management; Quality of life

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID;

ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMOTIONALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; QUALITY OF LIFE; REST; SCHOOL CHILD; SLEEP; TOPICAL TREATMENT;

ADMINISTRATION, CUTANEOUS; ADULT; AFFECTIVE SYMPTOMS; ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; EMOLLIENTS; FEMALE; HUMANS; HYGIENE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; YOUNG ADULT;

EID: 84857866982     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1560     Document Type: Article

References (25)

1. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358: 1483-94.
2. Fernandez-Mayoralas, Martin JM, Garcia-Marcos L. Prevalencia de la dermatitis atópica en escolares de Cartagena y su relación con el sexo y la contaminación. Anales de Pediatría 2004; 60: 555-60.
3. National Institute for Health and Clinical Excellence (NICE). Atopic Eczema in children: Management of atopic eczema in children from birth up to the age of 12 years. 2007.
4. Ponyai G, Hidvegi B, Nemeth I, Sas A, Temesvari E, Karpati S. Contact and aeroallergens in adulthood atopic dermatitis. J Eur Acad Dermatol Venereol 2008; 22: 1346-55.
5. Wollenberg A, Sidhu MK, Odeyemi I, et al. Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 2008; 159: 1322-30.
6. Wollenberg A, Reitamo S, Girolomoni G, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008;63:742-50.
7. Poole CD, Chambers C, Allsopp R, Currie CJ. Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids. J Eur Acad Dermatol Venereol 2010; 24: 674-8.
8. Holm EA, Esmann S, Jemec GB. The handicap caused by atopic dermatitis-sick leave and job avoidance. J Eur Acad Dermatol Venereol 2006;20:255-9.
9. McKenna SP, Doward LC. Quality of life of children with atopic dermatitis and their families. Curr Opin Allergy Clin Immunol 2008;8:228-31.
10. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60: 984-92.
11. Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006; 154:719-25.
12. Ben-Gashir MA, Seed PT, Hay RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 2002; 16: 455-62.
13. Holm EA, Wulf HC, Thomassen L, Jemec GB. Assessment of atopic eczema: clinical scoring and noninvasive measurements. Br J Dermatol 2007; 157:674-80.
14. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195:10-9.
15. Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U. K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol 1996; 135: 12-7.
16. Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: Development and Initial Validation of a New Tool for Measuring Atopic Eczema Severity From the Patients' Perspective. Arch Dermatol 2004;140: 1513-9.
17. Whalley D, McKenna SP, Dewar AL, et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 2004; 150:274-83.
18. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
19. Loo WJ, Diba V, Chawla M, Finlay AY. Dermatology Life Quality Index: influence of an illustrated version. Br J Dermatol 2003; 148:279-84.
20. Zuberbier T, Orlow SJ, Paller AS, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 2006; 118: 226-32.
21. Krejci-Manwaring J, Tusa MG, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 2007; 56: 211-6.
22. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142: 931-6.
23. Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Dermatovenerol Suppl (Stockh) 1980; 92: 44-7.
24. Weber MB, Fontes Neto PT, Prati C, et al. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol 2008; 22: 992-7.
25. Maroti M, Ulff E, Wijma B. Quality of life before and 6 weeks after treatment in a dermatological outpatient treatment unit. J Eur Acad Dermatol Venereol 2006; 20: 1081-5.